Published in J Virol on December 01, 1999
Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. J Virol (2002) 2.53
Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol (2003) 1.76
Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol (2007) 1.73
Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol (2008) 1.70
Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol (2004) 1.61
Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol (2010) 1.59
Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol (2001) 1.59
DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J Virol (2010) 1.45
Hepatitis C virus-like particle morphogenesis. J Virol (2002) 1.32
Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol (2005) 1.31
Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 1.22
The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro. Nucleic Acids Res (2004) 1.22
hepatitis c Virus p7 is critical for capsid assembly and envelopment. PLoS Pathog (2013) 1.20
HSP70 and its cochaperone CPIP promote potyvirus infection in Nicotiana benthamiana by regulating viral coat protein functions. Plant Cell (2010) 1.19
Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA (2002) 1.13
Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J Virol (2006) 1.11
Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol (2006) 1.08
Membrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells. J Virol (2004) 1.08
Brome mosaic virus capsid protein regulates accumulation of viral replication proteins by binding to the replicase assembly RNA element. RNA (2009) 1.05
Norovirus RNA synthesis is modulated by an interaction between the viral RNA-dependent RNA polymerase and the major capsid protein, VP1. J Virol (2012) 1.04
The dicistronic RNA from the mouse LINE-1 retrotransposon contains an internal ribosome entry site upstream of each ORF: implications for retrotransposition. Nucleic Acids Res (2006) 1.03
Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. RNA (2003) 1.01
Analysis of hepatitis C virus RNA dimerization and core-RNA interactions. Nucleic Acids Res (2006) 0.99
Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity. J Virol (2010) 0.98
A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay. Mol Cell (2015) 0.95
Role of RNA structures in genome terminal sequences of the hepatitis C virus for replication and assembly. J Virol (2009) 0.94
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet Vaccines Ther (2009) 0.93
Vitamin B12 and hepatitis C: molecular biology and human pathology. Proc Natl Acad Sci U S A (2001) 0.92
Non-encapsidation activities of the capsid proteins of positive-strand RNA viruses. Virology (2013) 0.89
Kinetic analysis of the nucleic acid chaperone activity of the hepatitis C virus core protein. Nucleic Acids Res (2010) 0.89
A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus. J Virol (2011) 0.87
N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection. Cell Host Microbe (2016) 0.87
The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression. Nucleic Acids Res (2008) 0.86
The 5' untranslated region and Gag product of Idefix, a long terminal repeat-retrotransposon from Drosophila melanogaster, act together to initiate a switch between translated and untranslated states of the genomic mRNA. Mol Cell Biol (2003) 0.85
Analysis of the RNA chaperoning activity of the hepatitis C virus core protein on the conserved 3'X region of the viral genome. Nucleic Acids Res (2011) 0.84
A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors. Anal Biochem (2007) 0.83
Identification of novel RNA secondary structures within the hepatitis C virus genome reveals a cooperative involvement in genome packaging. Sci Rep (2016) 0.82
A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors. Nucleic Acids Res (2008) 0.81
Conserved glycine 33 residue in flexible domain I of hepatitis C virus core protein is critical for virus infectivity. J Virol (2011) 0.81
Genetic clustering of hepatitis C virus strains and severity of recurrent hepatitis after liver transplantation. J Virol (2001) 0.80
Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein. J Virol (2004) 0.79
Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport. PLoS One (2014) 0.78
Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses. Cell Host Microbe (2017) 0.76
Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res (2010) 0.76
Fluorescence lifetime imaging of alterations to cellular metabolism by domain 2 of the hepatitis C virus core protein. PLoS One (2013) 0.76
Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells via a self-modulating mechanism. World J Gastroenterol (2003) 0.75
Exploiting cis-acting replication elements to direct hepatitis C virus-dependent transgene expression. J Virol (2005) 0.75
Last stop before exit - hepatitis C assembly and release as antiviral drug targets. Viruses (2010) 0.75
Cucumber mosaic virus coat protein modulates the accumulation of 2b protein and antiviral silencing that causes symptom recovery in planta. PLoS Pathog (2017) 0.75
Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants. PLoS Pathog (2017) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A (1990) 9.98
Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
Product review. New mammalian expression vectors. Nature (1990) 7.97
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science (1997) 7.53
Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A (1991) 7.15
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A (1997) 6.09
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 3.72
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J Virol (1998) 3.33
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol (1997) 2.98
Evidence for specificity in the encapsidation of Sindbis virus RNAs. J Virol (1989) 2.91
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol (1998) 2.71
The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A (1997) 2.43
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology (1996) 2.18
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis. Gene (1990) 2.12
Deletion analysis of the capsid protein of Sindbis virus: identification of the RNA binding region. J Virol (1993) 2.03
Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol (1996) 2.02
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol (1988) 1.92
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol (1997) 1.82
Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol (1999) 1.73
Molecular virology of hepatitis C virus. J Gen Virol (1997) 1.71
Interactions between Sindbis virus RNAs and a 68 amino acid derivative of the viral capsid protein further defines the capsid binding site. Nucleic Acids Res (1994) 1.70
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res (1995) 1.58
Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun (1995) 1.54
Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol (1995) 1.52
Homotypic interaction and multimerization of hepatitis C virus core protein. Virology (1996) 1.51
Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene (1998) 1.50
Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology (1997) 1.49
Suppression of apoptotic cell death by hepatitis C virus core protein. Virology (1996) 1.46
Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol (1997) 1.42
Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol (1996) 1.39
Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus. Arch Virol (1992) 1.36
Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag. J Virol (1996) 1.27
Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample. Hepatology (1998) 1.26
Transfection of HepG2 cells with infectious hepatitis C virus genome. Am J Pathol (1997) 1.23
Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods (1996) 1.20
A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase. Virology (1998) 1.11
Identification of domains in rubella virus genomic RNA and capsid protein necessary for specific interaction. J Virol (1996) 1.11
The sequence element of the internal ribosome entry site and a 25-kilodalton cellular protein contribute to efficient internal initiation of translation of hepatitis C virus RNA. J Virol (1997) 1.07
Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen Virol (1996) 1.05
Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol (1994) 1.03
Internal processing of hepatitis C virus NS3 protein. Virology (1999) 1.01
Detection of Cellular Proteins and Viral Core Protein Interacting with the 5' Untranslated Region of Hepatitis C Virus RNA. J Biomed Sci (1995) 0.84
Expression of target genes by coinfection with replication-deficient viral vectors. J Gen Virol (1998) 0.80
In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem (1996) 10.51
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol (1987) 6.41
The Arabidopsis ERECTA gene encodes a putative receptor protein kinase with extracellular leucine-rich repeats. Plant Cell (1996) 5.82
Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science (1997) 5.80
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med (1995) 3.74
Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science (1998) 3.39
Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan. Lancet (2000) 3.20
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol (1997) 2.98
Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem (1992) 2.90
Structure and possible catalytic residues of Taka-amylase A. J Biochem (1984) 2.89
KIF3A is a new microtubule-based anterograde motor in the nerve axon. J Cell Biol (1994) 2.86
Complete nucleotide sequence and genetic organization of Aichi virus, a distinct member of the Picornaviridae associated with acute gastroenteritis in humans. J Virol (1998) 2.85
cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol (2000) 2.83
Rom1p and Rom2p are GDP/GTP exchange proteins (GEPs) for the Rho1p small GTP binding protein in Saccharomyces cerevisiae. EMBO J (1996) 2.76
Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers. Nucleic Acids Res (1990) 2.76
Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis (1999) 2.52
Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process. Neuron (1998) 2.36
The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J Biol Chem (1999) 2.32
Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27
Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol (1997) 2.25
A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21. Proc Natl Acad Sci U S A (1991) 2.22
Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21
Immunochemical studies on human lung cancer antigens soluble in 50 per cent saturated ammonium sulfate. J Natl Cancer Inst (1968) 2.21
Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol (1999) 2.17
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
Characterization of pseudotype VSV possessing HCV envelope proteins. Virology (2001) 2.15
rac p21 is involved in insulin-induced membrane ruffling and rho p21 is involved in hepatocyte growth factor- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced membrane ruffling in KB cells. Mol Cell Biol (1994) 2.12
The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol (1997) 2.10
Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o) Nature (1993) 2.08
p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem (1998) 2.05
Telomerase activity in gastric cancer. Cancer Res (1995) 2.02
Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. Virus Res (1985) 1.92
Three-dimensional structure of a highly thermostable enzyme, 3-isopropylmalate dehydrogenase of Thermus thermophilus at 2.2 A resolution. J Mol Biol (1991) 1.92
Expression of processed core protein of hepatitis C virus in mammalian cells. J Virol (1991) 1.91
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 1.90
Intrafamilial transmission of hepatitis C virus. Lancet (1989) 1.90
Structure of cytochrome c551 from Pseudomonas aeruginosa refined at 1.6 A resolution and comparison of the two redox forms. J Mol Biol (1982) 1.88
Association of the myosin-binding subunit of myosin phosphatase and moesin: dual regulation of moesin phosphorylation by Rho-associated kinase and myosin phosphatase. J Cell Biol (1998) 1.85
Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol (1997) 1.82
Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase. J Biol Chem (1998) 1.81
Isolation and characterization of a GDP/GTP exchange protein specific for the Rab3 subfamily small G proteins. J Biol Chem (1997) 1.79
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology (1994) 1.74
Cdc42 and Rac1 regulate the interaction of IQGAP1 with beta-catenin. J Biol Chem (1999) 1.72
Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol (1992) 1.68
Regulation of cross-linking of actin filament by IQGAP1, a target for Cdc42. J Biol Chem (1997) 1.65
Neurabin: a novel neural tissue-specific actin filament-binding protein involved in neurite formation. J Cell Biol (1997) 1.64
Refined structure of cytochrome c3 at 1.8 A resolution. J Mol Biol (1984) 1.63
GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene (2000) 1.62
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology (1999) 1.60
Endovascular stent-grafting via the aortic arch for distal aortic arch aneurysm: an alternative to endovascular stent-grafting. Eur J Cardiothorac Surg (2001) 1.59
Isolation and characterization of a GTPase activating protein specific for the Rab3 subfamily of small G proteins. J Biol Chem (1997) 1.59
Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol (1982) 1.56
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol (1995) 1.52
Expression of hepatitis C virus NS5B protein: characterization of its RNA polymerase activity and RNA binding. Hepatology (1999) 1.52
Development and validation of an ultrasonographic activity index of Crohn's disease. Eur J Gastroenterol Hepatol (1999) 1.51
Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J Biol Chem (1992) 1.51
Cell fusion activity of hepatitis C virus envelope proteins. J Virol (2000) 1.50
Persistent BK papovavirus infection of transformed human fetal brain cells. I. Episomal viral DNA in cloned lines deficient in T-antigen expression. J Virol (1979) 1.50
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology (1998) 1.50
Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology (1997) 1.49
Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology (1999) 1.48
Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol (2001) 1.47
Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology (1994) 1.45
Two major antigenic polypeptides of molluscum contagiosum virus. J Infect Dis (1998) 1.44
Simple procedure of DNA isolation from human serum. Nucleic Acids Res (1991) 1.44
A novel irreversible inhibitor of acetylcholinesterase specifically directed at the anionic binding site: structure-activity relationships. Mol Pharmacol (1966) 1.43
Relationships of the anaerobic threshold with the 5 km, 10 km, and 10 mile races. Eur J Appl Physiol Occup Physiol (1982) 1.41
Strictureplasty for short duodenal stenosis in Crohn's disease. J Gastroenterol (2000) 1.39
Immunotherapy with paternal lymphocytes preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril (1992) 1.39
Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc Natl Acad Sci U S A (1991) 1.36
High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res (2000) 1.36
Genomic structure of human polyoma virus JC: nucleotide sequence of the region containing replication origin and small-T-antigen gene. J Virol (1983) 1.36
Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease. Ann Thorac Surg (1996) 1.35
Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res (1997) 1.34
Surgical correction of aneurysm of the sinus of Valsalva. A report of forty-five consecutive patients including eight with total replacement of the aortic valve. Am J Cardiol (1969) 1.34
Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus. J Gen Virol (1992) 1.34
Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus. J Antibiot (Tokyo) (1983) 1.32